HEMATOLOGY, cilt.22, sa.3, ss.136-144, 2017 (SCI-Expanded)
Introduction: The use of alpha beta+ T-cell-depleted grafts is a novel approach to prevent graft failure, graft-versus-host disease (GVHD), and non-relapse mortality (NRM) in patients undergoing haploidentical hematopoietic stem cell transplantation.